Cargando…

A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD

BACKGROUND: Mesenchymal stromal cells (MSCs) are a promising therapy for preventing chronic Graft-Versus-Host Disease (cGVHD) due to their potent immunomodulatory properties. However, the safety concerns regarding the use of MSCs remain unsolved, and conflicting effects are observed due to the heter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Peilong, Chen, Xiaomei, Guo, Liyan, Wang, Yulian, Liu, Xialin, Liu, Yan, Zhou, Tian, Huang, Tian, Geng, Suxia, Luo, Chengwei, Huang, Xin, Wu, Suijing, Ling, Wei, Du, Xin, He, Chang, Weng, Jianyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286548/ https://www.ncbi.nlm.nih.gov/pubmed/30526632 http://dx.doi.org/10.1186/s13045-018-0680-7

Ejemplares similares

Attenuation of cGVHD by C5a/C5aR blockade is associated with increased frequency of Treg
por: Wang, Yulian, et al.
Publicado: (2017)

Toll-like receptor 2–mediated NF-κB inflammatory responses in dry eye associated with cGVHD
por: He, Chang, et al.
Publicado: (2011)

Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting
por: Afram, Gabriel, et al.
Publicado: (2018)

Progress of cGVHD pathogenesis from the perspective of B cells
por: Li, Xiaoping, et al.
Publicado: (2019)

Effects of aGVHD and cGVHD on Survival Rate in Patients with Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation
por: Shokouhi, Shabnam, et al.
Publicado: (2015)

Lupus Recipe inhibits cGVHD‐induced lupus nephritis in mice and promote renal LC3‐associated autophagy
por: Liu, Ruihua, et al.
Publicado: (2023)

miR-204–containing exosomes ameliorate GVHD-associated dry eye disease
por: Zhou, Tian, et al.
Publicado: (2022)

The Gut Bacteria Dysbiosis Contributes to Chronic Graft-Versus-Host Disease Associated With a Treg/Th1 Ratio Imbalance
por: Wang, Yulian, et al.
Publicado: (2022)

Chronic Graft-Versus-Host Disease (cGVHD) Exacerbation after Sars-Cov-2 Covid Vaccination
por: Trunk, Andrew D., et al.
Publicado: (2021)

The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation
por: Metafuni, Elisabetta, et al.
Publicado: (2022)

慢性移植物抗宿主病（cGVHD）诊断与治疗中国专家共识（2021年版）
Publicado: (2021)

Salvage Therapy With Low-Dose Ruxolitinib Leads to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients With cGVHD After Allogeneic Hematopoietic Stem Cell Transplantation
por: Zhao, Yanmin, et al.
Publicado: (2021)

von Willebrand Factor as a Predictor for Transplant-Associated Thrombotic Microangiopathy
por: Xu, Zhenzhen, et al.
Publicado: (2020)

SARS-CoV-2 Infection and Active, Multiorgan, Severe cGVHD After HSCT for Adolescent ALL: More Luck Than Understanding? A Case Report
por: Zubarovskaya, Natalia, et al.
Publicado: (2022)

Dynamics of PD-1 expression are associated with treatment efficacy and prognosis in patients with intermediate/high-risk myelodysplastic syndromes under hypomethylating treatment
por: Geng, Suxia, et al.
Publicado: (2022)

Reduced Risk of Chronic Graft-Versus-Host Disease (cGVHD) by Rabbit Anti-Thymocyte Globulin (ATG) in Patients Undergoing Matched Sibling Donor Transplantation in Hematological Malignancies
por: Fang, Shu, et al.
Publicado: (2022)

C3aR costimulation enhances the antitumor efficacy of CAR-T cell therapy through Th17 expansion and memory T cell induction
por: Lai, Peilong, et al.
Publicado: (2022)

A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia
por: Weng, Jianyu, et al.
Publicado: (2018)

Correction to: A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia
por: Weng, Jianyu, et al.
Publicado: (2019)

Persistent donor derived Vδ4 T cell clones may improve survival for recurrent T cell acute lymphoblastic leukemia after HSCT and DLI
por: Xu, Ling, et al.
Publicado: (2016)

Challenges and advances in clinical applications of mesenchymal stromal cells
por: Zhou, Tian, et al.
Publicado: (2021)

Novel insights into MSC-EVs therapy for immune diseases
por: Lai, Peilong, et al.
Publicado: (2019)

C-Type Lectin-Like Molecule-1 as a Biomarker for Diagnosis and Prognosis in Acute Myeloid Leukemia: A Preliminary Study
por: Wang, Jinghua, et al.
Publicado: (2021)

Mesenchymal stem cells reversibly de-differentiate myofibroblasts to fibroblast-like cells by inhibiting the TGF-β-SMAD2/3 pathway
por: Xu, Ruohao, et al.
Publicado: (2023)

Mesenchymal Stem/Stromal Cell-Derived Exosomes for Immunomodulatory Therapeutics and Skin Regeneration
por: Ha, Dae Hyun, et al.
Publicado: (2020)

Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers
por: Bojanic, Ines, et al.
Publicado: (2023)

Deep learning-based transcriptome model predicts survival of T-cell acute lymphoblastic leukemia
por: Zhang, Lenghe, et al.
Publicado: (2022)

Exosomes, MDSCs and Tregs: A new frontier for GVHD prevention and treatment
por: Hess, Nicholas J., et al.
Publicado: (2023)

Identification and Validation of a Prognostic Risk-Scoring Model Based on Ferroptosis-Associated Cluster in Acute Myeloid Leukemia
por: Wang, Jinghua, et al.
Publicado: (2022)

Mesenchymal stromal cells ameliorate chronic GVHD by boosting thymic regeneration in a CCR9-dependent manner in mice
por: Zhang, Xin, et al.
Publicado: (2023)

T Helper Cell Lineage-Defining Transcription Factors: Potent Targets for Specific GVHD Therapy?
por: Campe, Julia, et al.
Publicado: (2022)

Mesenchymal stromal exosome–functionalized scaffolds induce innate and adaptive immunomodulatory responses toward tissue repair
por: Su, Ni, et al.
Publicado: (2021)

TLR2/4 deficiency prevents oxygen-induced vascular degeneration and promotes revascularization by downregulating IL-17 in the retina
por: He, Chang, et al.
Publicado: (2016)

Bcl-6-directed follicular helper T cells promote vascular inflammatory injury in diabetic retinopathy
por: Liu, Yan, et al.
Publicado: (2020)

Dynamic changes in serum cytokine levels and their clinical significance in predicting acute GVHD
por: Zhang, Chunyan, et al.
Publicado: (2017)

Bacterial flagellin—a potent immunomodulatory agent
por: Hajam, Irshad A, et al.
Publicado: (2017)

GVHD Prophylaxis 2020
por: Gooptu, Mahasweta, et al.
Publicado: (2021)

Modulation of Immunoregulatory Properties of Mesenchymal Stromal Cells by Toll-Like Receptors: Potential Applications on GVHD
por: Sangiorgi, Bruno, et al.
Publicado: (2016)

PB2179: RETROSPECTIVE ANALYSIS OF THE EFFICACY AND SAFETY OF RUXOLITINIB IN CHRONIC GRAFT VERSUS HOST DISEASE (CGVHD). A SINGLE-INSTITUTION EXPERIENCE.
por: Muñiz, Ó., et al.
Publicado: (2022)

Post-transplant cyclophosphamide for GVHD prophylaxis in pediatrics with chronic active Epstein-Barr virus infection after haplo-HSCT
por: Luo, Rongmu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4id95mq9c0vq3s3h5q3qmbv4vs